All Stories

  1. Assessment of adjunctive procedures during cesarean hysterectomy for placenta accreta spectrum
  2. [18F]FAPI-74 PET for Preoperative Assessment of Peritoneal Dissemination in Ovarian Cancer: A Case Series with Surgical and Histopathological Correlation
  3. Androgen Receptor as a Therapeutic Target in Endometrial Cancer: A Narrative Review
  4. Relative survival of large-cell to small-cell neuroendocrine carcinoma of the uterine cervix
  5. Reply
  6. Clinico-pathological characteristics and survival outcome associated with uterine leiomyosarcoma variants: epithelioid and myxoid types
  7. Association of sentinel lymph node biopsy and isolated tumor cells in cervical cancer
  8. Reply
  9. The value of vaginal cytology for postoperative surveillance of endometrial cancer
  10. A ninth-year follow-up survey of attitudes and behaviors of obstetricians and gynecologists toward HPV vaccination in Japan
  11. Nationwide assessment of COVID-19 ventilator and non-invasive respiratory support burden during the early pandemic in the United States
  12. Obesity and asthma during pregnancy: a systematic review and meta-analysis
  13. Intrauterine manipulator use during laparoscopic hysterectomy for endometrial cancer: association for pathological factors and oncologic outcomes
  14. Salvage hysterectomy for persistent residual cervical cancer: assessment of prognostic factors
  15. Population-Based Survival Analysis of Stage IVB Small-Cell Neuroendocrine Carcinoma in Comparison to Major Histological Subtypes of Cervical Cancer
  16. Systematic Review of the Survival Outcomes of Neoadjuvant Chemotherapy in Women with Malignant Ovarian Germ Cell Tumors
  17. Port‐site hernia: A potentially severe complication of minimally invasive surgery
  18. Relationship between Abnormal Placenta and Obstetric Outcomes: A Meta-Analysis
  19. Comparison of the Survival Outcomes of Minimally Invasive Surgery with Open Surgery in Patients with Uterine-Confined and Node-Negative Cervical Cancer: A Population-Based Study
  20. Vertical compression suture for placenta previa: Using a dedicated needle for uterine compression suture to achieve longitudinal shrinkage of the uterus
  21. Current Evidence on Vasa Previa without Velamentous Cord Insertion or Placental Morphological Anomalies (Type III Vasa Previa): Systematic Review and Meta-Analysis
  22. The Characteristics and Obstetric Outcomes of Type II Vasa Previa: Systematic Review and Meta-Analysis
  23. Surgical Management for Transposed Ovarian Recurrence of Cervical Cancer: A Systematic Review with Our Experience
  24. Placenta Accreta Spectrum and Hypertensive Disorders of Pregnancy: Concerns Regarding the Difference in Length of Pregnancy
  25. Assisted Reproductive Technique and Abnormal Cord Insertion: A Systematic Review and Meta-Analysis
  26. The Effect of Surgeon Volume on the Outcome of Laser Vaporization: A Single-Center Retrospective Study
  27. Association between Endometriosis and Delivery Outcomes: A Systematic Review and Meta-Analysis
  28. Placenta Accreta Spectrum Disorder Complicated with Endometriosis: Systematic Review and Meta-Analysis
  29. Conservative management of placenta percreta: is current evidence sufficient?
  30. Placenta Previa Complicated with Endometriosis: Contemporary Clinical Management, Molecular Mechanisms, and Future Research Opportunities
  31. Minimally Invasive Surgery and Surgical Volume-Specific Survival and Perioperative Outcome: Unmet Need for Evidence in Gynecologic Malignancy
  32. Effects of aspirin and statin use on venous thromboembolism prophylaxis and survival in patients with endometrial cancer
  33. The association of endometriosis with placenta previa and postpartum hemorrhage: a systematic review and meta-analysis
  34. A systematic review and meta-analysis of obstetric and maternal outcomes after prior uterine artery embolization
  35. CD70 antibody‐drug conjugate: A potential novel therapeutic agent for ovarian cancer
  36. Unmet need for evidence of volume–outcome relation and maternal outcomes of placenta accreta spectrum
  37. Characteristics and outcomes of women with adenocarcinoma versus squamous cell carcinoma of the vulva: A Japanese Gynecologic Oncology Group study
  38. Clinico‐pathological significance of suspicious peritoneal cytology in endometrial cancer
  39. Effect of in vitro fertilization–embryo transfer on placenta accreta spectrum according to treatment type
  40. Stinging abdominal pain at 32 gestational weeks with prior classical uterine incision: Careful assessment or emergency cesarean delivery?
  41. Antenatal diagnosis of placenta accreta spectrum after in vitro fertilization-embryo transfer: a systematic review and meta-analysis
  42. Intersection of DNA Repair Pathways and the Immune Landscape Identifies PD-L2 as a Prognostic Marker in Epithelial Ovarian Cancer
  43. Emerging Trends in Neoadjuvant Chemotherapy for Ovarian Cancer
  44. Hysterectomy versus continuing conservative management: which is better for disseminated intravascular coagulation?
  45. Placenta previa with posterior extrauterine adhesion: clinical features and management practice
  46. Possible candidate population for neoadjuvant chemotherapy in women with advanced ovarian cancer
  47. Proposing the 3‐tier staging system for improving prognostication in Stage I uterine leiomyosarcoma
  48. Survival effect of intra-operative tumor spillage during minimally invasive hysterectomy for early-stage endometrial cancer: a call for research
  49. In-vitro fertilisation–embryo-transfer complicates the antenatal diagnosis of placenta accreta spectrum using MRI: a retrospective analysis
  50. Reply
  51. Evaluation of leucine-rich alpha-2 glycoprotein as a biomarker of fetal infection
  52. National trends and outcomes of morbidly obese women who underwent inpatient hysterectomy for benign gynecological disease in the USA
  53. Conservative management for adherent placenta after live birth in angular or interstitial pregnancies: A new entity “angular placenta attachment”
  54. Effect of delay in surgical therapy for early-stage cervical cancer: An implication in the coronavirus pandemic
  55. Malignant peritoneal cytology in endometrial cancer: Areas of unmet need for evidence
  56. The rapid adoption of opportunistic salpingectomy at the time of hysterectomy for benign gynecologic disease in the United States
  57. Uterine carcinosarcoma: Contemporary clinical summary, molecular updates, and future research opportunity
  58. Semi-quantification of grade 2 endometrioid endometrial cancer: A rationale of inter-observer agreement per pathologists
  59. Side-to-end reanastomosis after lower anterior resection (STELAR) in Gynecologic Cancer Surgery
  60. Unified interpretation of scalegenesis in conformally extended standard models: a dynamical origin of Higgs portal *
  61. ASO Author Reflections: Spotlight on Malignant Peritoneal Cytology in Uterine Sarcoma: A Potential Avenue for Future Research
  62. Management of recurrent granulosa cell tumor of the ovary: Contemporary literature review and a proposal of hyperthermic intraperitoneal chemotherapy as novel therapeutic option
  63. Significance of Malignant Peritoneal Cytology on Survival of Women with Uterine Sarcoma
  64. Malignant peritoneal cytology and increased mortality risk in stage I non-endometrioid endometrial cancer
  65. Proposal of an endometrial cancer staging schema with stage-specific incorporation of malignant peritoneal cytology
  66. Diagnosis shift between low-grade serous ovarian cancer and serous borderline ovarian tumor: A population-based study
  67. Differences in effectiveness of concurrent metformin with local versus systemic progestin therapy for obese women with complex atypical hyperplasia
  68. Dynamic scale anomalous transport in QCD with electromagnetic background
  69. Evolving population-based statistics for rare epithelial ovarian cancers
  70. Incidence and characteristics of subsequent breast cancer after uterine cancer: A population-based analysis
  71. Malignant peritoneal cytology and decreased survival of women with stage I endometrioid endometrial cancer
  72. Minimally invasive surgery for early-stage ovarian cancer: Association between surgical volume and perioperative outcomes
  73. EFFECT OF HOSPITAL VOLUME ON THE INCIDENCE OF MAJOR COMPLICATIONS IN PATIENTS HOSPITALIZED WITH OVARIAN HYPERSTIMULATION SYNDROME
  74. IMPACT OF BODY HABITUS ON INCIDENCE OF COMPLICATIONS IN PATIENTS HOSPITALIZED WITH OVARIAN HYPERSTIMULATION SYNDROME
  75. Nonlinear Optics with Near-Infrared Excitation Enable Real-Time Quantitative Diagnosis of Human Cervical Cancers
  76. Financial viewpoint of minimally invasive radical hysterectomy for early cervical cancer: another disadvantage?
  77. CD70 antibody-drug conjugate as a potential therapeutic agent for uterine leiomyosarcoma
  78. Minimally invasive radical hysterectomy for early-stage cervical cancer: Volume-outcome relationship in the early experience period
  79. Sonographic findings after induced medical abortion at 12–21 weeks of gestation: Retrospective cohort study
  80. Malignant peritoneal cytology and decreased survival of women with stage I endometrioid endometrial cancer
  81. Minimally Invasive Surgery and Risk of Capsule Rupture for Women With Early-Stage Ovarian Cancer
  82. Minimally invasive surgery for early-stage ovarian cancer: Association between hospital surgical volume and short-term perioperative outcomes
  83. Progestin therapy for obese women with complex atypical hyperplasia: levonorgestrel-releasing intrauterine device vs systemic therapy
  84. Wait-time for hysterectomy and survival of women with early-stage cervical cancer: A clinical implication during the coronavirus pandemic
  85. Fertility‐sparing treatment for early‐stage epithelial ovarian cancer: Contemporary oncologic, reproductive and endocrinologic perspectives
  86. Utility of the 3-tier grouping system for survival discriminatory ability in stage IIA cervical cancer
  87. Molecular Pathways and Targeted Therapies for Malignant Ovarian Germ Cell Tumors and Sex Cord–Stromal Tumors: A Contemporary Review
  88. Proposal of a Two-Tier System in Grouping Adenocarcinoma of the Uterine Cervix
  89. Route-specific association of progestin therapy and concurrent metformin use in obese women with complex atypical hyperplasia
  90. Cesarean radical hysterectomy for cervical cancer in the United States: a national study of surgical outcomes
  91. Populational trends and outcomes of postoperative radiotherapy for high-risk early-stage cervical cancer with lymph node metastasis: concurrent chemo-radiotherapy versus radiotherapy alone
  92. Inverse mass hierarchy of light scalar mesons driven by anomaly-induced flavor breaking
  93. Significance of lymph node ratio on survival of women with borderline ovarian tumors
  94. Delayed hysterectomy versus continuing conservative management for placenta percreta: Which is better?
  95. Association between hospital surgical volume and perioperative outcomes of fertility-sparing trachelectomy for cervical cancer: A national study in the United States
  96. Diagnosis-shift between low-grade serous ovarian cancer and serous borderline ovarian tumor: A population-based study
  97. Evolving population-based statistics for rare epithelial ovarian cancers
  98. Temporal trends of subsequent breast cancer among women with ovarian cancer: a population-based study
  99. Conservative surgery for ovarian torsion in young women: perioperative complications and national trends
  100. Obstetric Outcomes of Pregnancy After Uterine Artery Embolization
  101. Management of Stage IIB Cervical Cancer: an Overview of the Current Evidence
  102. PD-1+ Tim3+ tumor-infiltrating CD8 T cells sustain the potential for IFN-γ production, but lose cytotoxic activity in ovarian cancer
  103. Chiral-imbalance density wave in baryonic matters
  104. Minimally invasive interval debulking surgery after neoadjuvant chemotherapy for metastatic ovarian cancer: a national study in the United States
  105. Changing attitudes in Japan toward HPV vaccination: a 5-year follow-up survey of obstetricians and gynecologists regarding their current opinions about the HPV vaccine
  106. Implementation of Multidisciplinary Practice Change to Improve Outcomes for Women with Placenta Accreta Spectrum
  107. Efficacy of Prophylactic Antibiotics in Bakri Intrauterine Balloon Placement: A Single-Center Retrospective Analysis and Literature Review
  108. Persistent funic presentation due to velamentous cord insertion adjacent to the internal os but not vasa previa
  109. 527: Implementation of multidisciplinary policy to improve outcomes for women with morbidly adherent placental disease
  110. Horizontal Cervix as a Novel Sign for Predicting Adhesions on the Posterior Extrauterine Wall in Cases of Placenta Previa
  111. Systematic review on the needle and suture types for uterine compression sutures: a literature review
  112. Emerging serine-threonine kinase inhibitors for treating ovarian cancer
  113. Endometrial carcinoma in a gravid uterus: a case report and literature review
  114. Hospital surgical volume and perioperative mortality of pelvic exenteration for gynecologic malignancies
  115. Significance of Malignant Peritoneal Cytology on the Survival of Women with Early-Stage Cervical Cancer: A Japanese Gynecologic Oncology Group Study
  116. Vesicoureteral Injury during Benign Hysterectomy: Minimally Invasive Laparoscopic Surgery versus Laparotomy
  117. Temporal trends and characteristics of suicide among women with gynecologic malignancy in the United States
  118. EP1084 The change of opinions on HPV vaccination in Japan: a 5-year follow-up survey of obstetricians and gynecologists regarding their opinions about the HPV vaccine
  119. A rare type of vasa previa
  120. Treatment and outcome of placenta percreta: primary cesarean hysterectomy versus conservative management
  121. Histologic correlation between smartphone and coloposcopic findings in patients with abnormal cervical cytology: experiences in a tertiary referral hospital
  122. Letter to “Cervical varices unrelated to placenta previa as an unusual cause of antepartum hemorrhage: A case report and literature review”: Successful management of postpartum hemorrhage due to cervical varix: Modified Matsubara Nelaton method using B...
  123. Preeclampsia: Maternal Systemic Vascular Disorder Caused by Generalized Endothelial Dysfunction Due to Placental Antiangiogenic Factors
  124. Copper ions are novel therapeutic agents for uterine leiomyosarcoma
  125. Abstract 3853: CD70 antibody-drug conjugate: A novel therapeutic agent for platinum-resistant ovarian carcinoma
  126. Abstract 33:Ex vivodrug sensitivity assay with a panel of cancer patient-derived spheroids of small cell neuroendocrine carcinoma of uterine cervix
  127. Abstract 3029: Targeting Annexin A4 with antisense oligonucleotides improves platinum resistance of ovarian cancer
  128. Enhanced di-Higgs signal from hidden scalar QCD at leading-order in the scale-symmetry limit
  129. Trends in incidence and long-term survival of Japanese women with vulvar cancer: a population-based analysis
  130. New dedicated blunt straight needles and sutures for uterine compression sutures: a retrospective study and literature review
  131. When is the ideal time to remove cerclage in cases requiring cesarean hysterectomy for placenta accreta spectrum?
  132. Relation between the number of board‐certified gynecologic oncologists per hospital and survival of cervical cancer
  133. HPV vaccination in Japan: what is happening in Japan?
  134. Single versus multiple cervical dilation by osmotic dilator before induction of labor for second‐trimester abortion
  135. Cover Image
  136. Vasa Previa
  137. Epidemiologic and Clinical Analysis of Cervical Cancer Using Data from the Population-Based Osaka Cancer Registry
  138. Laparoscopic Radical Hysterectomy
  139. Gross image of vasa previa restored in the postpartum period
  140. Retrospective analysis for predictors of parametrial involvement in IB cervical cancer
  141. Small Cell Carcinomas of the Uterine Cervix and Lung: Proteomics Reveals Similar Protein Expression Profiles
  142. Magnetic field effect on nuclear matter from a Skyrmion crystal model
  143. An evident asymmetrical uterus during cesarean delivery
  144. A phase I/II study of GLIF combination chemotherapy for taxane/platinum-refractory/resistant endometrial cancer (GOGO-EM2)
  145. Abstract 1434: LSR promotes lipid metabolism via beta oxidation and contributes cell viability in epithelial ovarian cancer
  146. Obstetric outcomes and acceptance of alternative therapies to blood transfusion by Jehovah’s Witnesses in Japan: a single-center study
  147. Intratumoral Delivery of an Adenoviral Vector Carrying theSOCS-1Gene Enhances T-Cell–Mediated Antitumor Immunity By Suppressing PD-L1
  148. Obstetric outcome in patients with a unicornuate uterus after laparoscopic resection of a rudimentary horn
  149. Conservative management of placenta percreta
  150. Motivating Mothers to Recommend Their 20-Year-Old Daughters Receive Cervical Cancer Screening: A Randomized Study
  151. One-family walking technicolor in light of LHC Run II
  152. Successful anticoagulant therapy for disseminated intravascular coagulation during conservative management of placenta percreta: a case report and literature review
  153. LSR Antibody Therapy Inhibits Ovarian Epithelial Tumor Growth by Inhibiting Lipid Uptake
  154. Anti-glypican-1 antibody-drug conjugate exhibits potent preclinical antitumor activity against glypican-1 positive uterine cervical cancer
  155. HPV vaccination in Japan: results of a 3-year follow-up survey of obstetricians and gynecologists regarding their opinions toward the vaccine
  156. LSR PROMOTES LIPID UPTAKE, BETA-OXIDATION AND SUBSEQUENT TUMOR GROWTH IN OVARIAN CANCER
  157. Descriptive epidemiological study of vaginal cancer using data from the Osaka Japan population-based cancer registry
  158. Investigation of perioperative complications associated with use of uterine compression sutures
  159. Abstract 1397: Antisense oligo nucleotide of Annexin A4 improved platinum resistance in ovarian clear cell cancer
  160. Abstract 1200: Novel strategy to overcome platinum resistance in uterine leiomyosarcoma; blocking ATP7B by copper ion
  161. A case of acute Sheehan’s syndrome and literature review: a rare but life-threatening complication of postpartum hemorrhage
  162. Predictors for recurrent/persistent high-grade intraepithelial lesions and cervical stenosis after therapeutic conization: a retrospective analysis of 522 cases
  163. Pregnancy outcomes in women with different doses of corticosteroid supplementation during labor and delivery
  164. Lifetime of rho meson in correlation with magnetic-dimensional reduction
  165. ‘Smartscopy’ as an alternative device for cervical cancer screening: a pilot study
  166. Realistic fear of cervical cancer risk in Japan depending on birth year
  167. Vasa previa with an intact amniotic membrane
  168. Treatment and repair of uterine scar dehiscence during cesarean section
  169. A case report of a successful pregnancy in a woman diagnosed with common variable immunodeficiency with impaired B cell class-switching and the decrease in naïve CD4 positive T cell
  170. Placenta accreta following laparoscopic adenomyomectomy: a case report
  171. Project conducted in Hirakata to improve cervical cancer screening rates in 20-year-old Japanese: Influencing parents to recommend that their daughters undergo cervical cancer screening
  172. Successful conservative management of placenta percreta: Investigation by serial magnetic resonance imaging of the clinical course and a literature review
  173. Response to ‘Letter to “Cervical varix complicated by placenta previa: A case report and literature review”: A novel simple abdominal traction stitch (Matsubara) to hold the Bakri balloon’
  174. Abstract 4998: Lipolysis-stimulated lipoprotein receptor (LSR) can be a novel therapeutic target of ovarian cancer
  175. Short interpregnancy interval after B-Lynch uterine compression suture: a case report
  176. Chemotherapy for Uterine Sarcomas: A Review
  177. Placenta accreta following hysteroscopic myomectomy
  178. Cesarean delivery via a transverse uterine fundal incision for the successful management of a low-lying placenta and aplastic anemia
  179. Significance of histologic pattern of carcinoma and sarcoma components on survival outcomes of uterine carcinosarcoma
  180. Cervical varix complicated by placenta previa: A case report and literature review
  181. Similar protein expression profiles of ovarian and endometrial high-grade serous carcinomas
  182. Long-term survival in small-cell carcinoma of the endometrium with liver and brain metastases
  183. Utility of an Internal Retractor (EndoGrab) for the Management of the Vesicouterine Ligament during Laparoscopic Radical Hysterectomy
  184. Clinical outcomes of abnormal cervical cytology and human papillomavirus-related lesions in patients with organ transplantation: 11-year experience at a single institution
  185. Early metabolic change in 18F-FDG-PET by measuring the single largest lesion predicts chemotherapeutic effects and patients’ survival: PEACH study
  186. Potential targets for ovarian clear cell carcinoma: a review of updates and future perspectives
  187. A Case of Extragonadal Teratoma in the Pouch of Douglas and Literature Review
  188. CpG oligodeoxynucleotides potentiate the antitumor activity of anti‐ BST 2 antibody
  189. Human papillomavirus vaccination of the daughters of obstetricians and gynecologists in Japan
  190. A novel device for cleaning the camera port during laparoscopic surgery
  191. Trends in the cervical cancer screening rates in a city in Japan between the years of 2004 and 2013
  192. Managing cesarean section in a patient with rotated uterus due to a large myoma
  193. Optimal Timing for Drainage of Infected Lymphocysts After Lymphadenectomy for Gynecologic Cancer
  194. A Case Report and Literature Review of Midtrimester Termination of Pregnancy Complicated by Placenta Previa and Placenta Accreta
  195. Pregnancy management for a patient with graft occlusion after right iliac artery bypass surgery
  196. Clear cell adenocarcinoma of the peritoneum: a case report and literature review
  197. Annexin A4 induces platinum resistance in a chloride-and calcium-dependent manner
  198. Placenta percreta managed by transverse uterine fundal incision with retrograde cesarean hysterectomy: a novel surgical approach
  199. Large Uterine Cervical Adenomyoma Excised by Vaginal Approach: Case Report, Images, and Literature Review
  200. Interstitial Pregnancy Resulting in a Viable Infant Coexistent with Massive Perivillous Fibrin Deposition: A Case Report and Literature Review
  201. Annexin A4 is a promising therapeutic target for the treatment of platinum-resistant cancers
  202. Placenta percreta with a vaginal fistula after successful management by uterine transverse fundal incision and subsequent cesarean hysterectomy
  203. Challenges in Diagnosis of Pseudo Vasa Previa
  204. Successful management of placenta percreta by cesarean hysterectomy with transverse uterine fundal incision
  205. Annexin A4-conferred platinum resistance is mediated by the copper transporter ATP7A
  206. Endometrial Thickness Measured by Ultrasonography in Postmenopausal Patients With Endometrial Carcinoma Has Significance, Irrespective of Histological Subtype
  207. Abstract 4059: Annexin A4-conferred platinum resistance is mediated by the copper transporter ATP7A.
  208. Abstract 4057: Functional domain of Annexin A4: which domain is indispensable for chemoresistance to platinum drugs.
  209. Taxane-sensitivity of ovarian carcinomas previously treated with paclitaxel and carboplatin
  210. Disease flare-ups and obstetric outcomes in pregnant women with systemic lupus erythematosus
  211. Vulvovaginal aggressive angiomyxoma mimicking lymphedema complicated with Behcet’s disease: a case report and review of the literature
  212. Serum leucine-rich alpha-2 glycoprotein is a disease activity biomarker in ulcerative colitis
  213. Biomarkers for Screening, Diagnosis, and Monitoring of Ovarian Cancer
  214. Plasma membrane proteomics identifies bone marrow stromal antigen 2 as a potential therapeutic target in endometrial cancer
  215. Abstract 4225: Annexin A4 induces chemoresistance for multiple drugs in ovarian clear cell carcinoma
  216. Prediction, based on resection margins, of long-term outcome of cervical intraepithelial neoplasia 3 treated by Shimodaira-Taniguchi conization
  217. Intraoperative Frozen Section Assessment of Myometrial Invasion and Histology of Endometrial Cancer Using the Revised FIGO Staging System
  218. Recurrent endometrial carcinoma: prognosis for patients with recurrence within 6 to 12 months is worse relative to those relapsing at 12 months or later
  219. Abstract 5108: Quantitative proteomic analysis of cell-surface membrane proteins: Biomarker discovery in endometrial cancer
  220. Expression of aldehyde dehydrogenase 1 (ALDH1) in endometrioid adenocarcinoma and its clinical implications
  221. CRABP1-reduced expression is associated with poorer prognosis in serous and clear cell ovarian adenocarcinoma
  222. Second-line chemotherapy for advanced or recurrent endometrial carcinoma previously treated with paclitaxel and carboplatin, with or without epirubicin
  223. Endometrial carcinoma: better prognosis for asymptomatic recurrences than for symptomatic cases found by routine follow-up
  224. A Case of Disseminated Peritoneal Leiomyomatosis Developing after Laparoscope-Assisted Myomectomy
  225. Cesarean delivery after successful external cephalic version of breech presentation at term